Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge
- 19 August 1988
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 260 (7) , 974-976
- https://doi.org/10.1001/jama.260.7.974
Abstract
Thirty patients with ocular melanoma metastatic to the liver were treated by hepatic arterial chemoembolization using an admixture of cisplatin and polyvinyl sponge. Tumor regression was complete in one patient and partial (>50%) in 13 patients. The total response rate was 46%. The median survival for the entire group was 11 months (95% confidence interval, nine to 18 months). Treatmentrelated morbidity was short-lived and included primarily severe upper right quadrant abdominal pain, transient paralytic ileus, and nonicteric hepatitis. Hepatic arterial chemoembolization provided effective palliation, with goodquality survival among 46% of patients with ocular melanoma metastatic to the liver. (JAMA1988;260:974-976)This publication has 4 references indexed in Scilit:
- Treatment of hepatic metastases in ocular melanoma. Embolization of the hepatic artery with polyvinyl sponge and cisplatinJAMA, 1986
- Survival in metastatic ocular melanomaCancer, 1983
- Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liverCancer, 1983
- Prognosis In Metastatic Choroidal MelanomaSouthern Medical Journal, 1981